News

New EUHA position paper highlights the role of university hospitals in sustainable care

11 September 2024

This week the European University Hospital Alliance (EUHA) published its position paper 'Rethinking Healthcare Systems'. Among other things, the paper pushes forward three key action points to ensure the future of European healthcare. Discover them here.

New storage method for donor hearts surpasses traditional storage on ice

5 September 2024

A UZ Leuven study shows the benefits of machine perfusion for longer and safer storage of donor hearts pending transplantation.

New warehouse makes hospital pharmacy future-proof

8 August 2024

In June the UZ Leuven hospital pharmacy got a brand-new warehouse, which is high-tech and future-oriented, including a lot of robotics. In a few years's time it will be further expanded to include a central compounding pharmacy, which will play a major role within the regional Plexus hospital network.

Immunotherapy can prevent dangerous blood transfusion in foetus

8 August 2024

A new study shows that the drug nipocalimab is a good alternative for the not harmless blood transfusion in a rhesus pregnancy: the drug ensures that the mother's antibodies can no longer go to the foetus.

Prof. Paul Herijgers starts as CEO of UZ Leuven

5 August 2024

On Monday 5 August prof. dr. Paul Herijgers starts as the new CEO of UZ Leuven. What will be the focus for the coming years? And what motivates him to take on the job of manager of UZ Leuven?

Leuven study unravels underlying mechanism of intestinal fibrosis

24 July 2024

Despite advancements in treating chronic inflammation, existing anti-inflammatory medications cannot prevent the development of intestinal fibrosis. Researchers from UZ Leuven and KU Leuven now identified several mechanisms crucial for the development of intestinal fibrosis in a recent study. With this information, they hope to develop potential new treatments.

UZ Leuven largest centre in Belgium for life-saving PEA treatment

17 July 2024

UZ Leuven saccounts for the largest number of pulmonary endarteriectomies in Belgium, with remarkably good survival rates. The cardio-surgeons and pulmonologists involved nurture an ambitious vision for the future: centralise the procedure even more and aim for at least 33 operations a year.

Radioligand therapy is gaining momentum

19 June 2024

UZ Leuven uses radioligand therapy for metastatic neuroendocrine tumours and in patients with advanced prostate cancer who were no longer experiencing any effect from conventional chemotherapy or radiotherapy.

Investment support for UZ Leuven construction projects

6 June 2024

The Flemish government informed the press today that UZ Leuven can count on 14.7 million annual investment support for important infrastructure works. There are new building projects in the pipeline in Leuven that are important for both patients and staff.

New biomarker predicts success of immunotherapy in kidney cancer

21 May 2024

Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team developed a new method to predict which patients will benefit from it. Their study, published in the journal Nature Medicine, also opens new avenues to even more effective treatments.

First results gene therapy for frontotemporal degeneration are promising

14 May 2024

UZ Leuven has been collaborating on an internationl clinical study on gene replacement in FTD with progranulin mutation.

Cancer radiation during pregnancy safe for unborn child

18 April 2024

Cancer radiation during pregnancy is safe for the unborn child, a long-term study from UZ Leuven has shown. The research team brings long-term results of the psychological and physical impact on a child after radiotherapy in the mother during pregnancy for the first time.